Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - China Shenghuo Pharmaceutical Holdings Inc | v229655_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex31-1.htm |
| EX-10.3 - EXHIBIT 10.3 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex10-3.htm |
| EX-10.1 - EXHIBIT 10.1 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex10-1.htm |
| EX-10.5 - EXHIBIT 10.5 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex10-5.htm |
| EX-10.2 - EXHIBIT 10.2 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex10-2.htm |
| EX-31.2 - EXHIBIT 31.2 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex31-2.htm |
| EX-10.6 - EXHIBIT 10.6 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex10-6.htm |
| EXCEL - IDEA: XBRL DOCUMENT - China Shenghuo Pharmaceutical Holdings Inc | Financial_Report.xls |
| EX-10.4 - EXHIBIT 10.4 - China Shenghuo Pharmaceutical Holdings Inc | v229655_ex10-4.htm |
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of China Shenghuo Pharmaceutical Holdings, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
|
(1)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Feng Lan
|
|
Name: Feng Lan
|
|
Title: Chief Executive Officer and President
|
|
/s/ Raymond Wang
|
|
Name: Raymond Wang
|
|
Title: Chief Financial Officer
|
August 15, 2011
A signed original of this written statement required by Section 906 has been provided to China Shenghuo Pharmaceutical Holdings, Inc. and will be retained by China Shenghuo Pharmaceutical Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.